Evidence map›Paper›PMID 21805638›Full record

ArticleProteomics2011

Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Roger A Moore, Andrew G Timmes, Phillip A Wilmarth, David Safronetz, Suzette A Priola

Open access · greenAbstract read
In one paragraph

Article in Proteomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prion Strain Diversity.Cold Spring Harbor perspectives in medicine · 2016
    Review
  6. Article
  7. Article
  8. Techniques to elucidate the conformation of prions.World journal of biological chemistry · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Roger A MooreRocky Mountain Laboratories/Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 S. 4th St., Hamilton, MT 59840, USA. rmoore@niaid.nih.gov
Andrew G Timmes
Phillip A Wilmarth
David Safronetz
Suzette A Priola
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USOregon Health & Science University · US

Funding

Molecular Genetics Of Scrapie PathogenesisZIAAI000752 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PRIOLA, SUZETTE ALISE · 2009 to 2025
$15.5M
Molecular Mechanisms of Prion Protein Amyloid FormationZIAAI001105 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PRIOLA, SUZETTE ALISE · 2009 to 2025
$7.3M
MOLECULAR GENETICS OF SCRAPIE PATHOGENESISZ01AI000752 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PRIOLA, SUZETTE ALISE · 1996 to 2008
$3.7M
PROTEIN CLEAVAGE SITES IN EXPERIMENTAL CATARACTOUS LENSR01EY007755 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID, LARRY L · 1995 to 2014
$3.6M
PROTEIN CLEAVAGE SITES IN EXPERIMENTAL CATARACTOUS LENSER29EY007755 · NEI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI DAVID, LARRY L · 1989 to 1993
–
Intramural NIH HHS Z01 AI000752Intramural NIH HHS Z99 AI999999NEI NIH HHS EY007755NEI NIH HHS R01 EY007755NIAID NIH HHS AI000752-16NIAID NIH HHS Y99 AI999999
6 · The paper itself

Abstract

Prion diseases are neurodegenerative disorders associated with the accumulation of an abnormal isoform of the mammalian prion protein (PrP). Fourier transform infrared spectroscopy (FTIR) has previously been used to show that the conformation of aggregated, infectious PrP (PrP(Sc) ) varies between prion strains and these unique conformations may determine strain-specific disease phenotypes. However, the relative amounts of α-helix, β-sheet and other secondary structures have not always been consistent between studies, suggesting that other proteins might be confounding the analysis of PrP(Sc) secondary structure. We have used FTIR and LC-MS/MS to analyze enriched PrP(Sc) from mouse and hamster prion strains both before and after the removal of protein contaminants that commonly co-purify with PrP(Sc) . Our data show that non-PrP proteins do contribute to absorbances that have been associated with α-helical, loop, turn and β-sheet structures attributed to PrP(Sc) . The major contaminant, the α-helical protein ferritin, absorbs strongly at 1652 cm(-1) in the FTIR spectrum associated with PrP(Sc) . However, even the removal of more than 99% of the ferritin from PrP(Sc) did not completely abolish absorbance at 1652 cm(-1) . Our results show that contaminating proteins alter the FTIR spectrum attributed to PrP(Sc) and suggest that the α-helical, loop/turn and β-sheet secondary structure that remains following their removal are derived from PrP(Sc) itself.

Indexed as

AnimalsChromatography, High Pressure LiquidCricetinaeFerritinsHumansMicePrion DiseasesProtein BindingProteinsProtein Structure, SecondaryProteomicsPrPSc ProteinsSpectroscopy, Fourier Transform InfraredTandem Mass SpectrometryFerritinsProteinsPrPSc Proteins

Identifiers

PMID21805638
PMCPMC3727666
OpenAlexW2059195925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.